| Primary |
| Product Used For Unknown Indication |
34.5% |
| Drug Use For Unknown Indication |
20.3% |
| Hypertonic Bladder |
9.6% |
| Enuresis |
4.0% |
| Urinary Incontinence |
4.0% |
| Bladder Spasm |
3.4% |
| Incontinence |
3.4% |
| Neurogenic Bladder |
3.4% |
| Pollakiuria |
3.4% |
| Investigation |
2.3% |
| Drug Abuse |
1.7% |
| Stress Urinary Incontinence |
1.7% |
| Alcoholism |
1.1% |
| Convulsion |
1.1% |
| Micturition Urgency |
1.1% |
| Osteoarthritis |
1.1% |
| Salivary Hypersecretion |
1.1% |
| Urge Incontinence |
1.1% |
| Urinary Tract Infection |
1.1% |
| Affective Disorder |
0.6% |
|
| Thinking Abnormal |
14.6% |
| Urinary Tract Infection |
10.4% |
| Death |
8.3% |
| Drug Ineffective |
8.3% |
| Pharmaceutical Product Complaint |
6.3% |
| Psychotic Disorder |
6.3% |
| Sedation |
6.3% |
| Drug Dependence |
4.2% |
| Hyperthermia |
4.2% |
| Lumbar Vertebral Fracture |
4.2% |
| Non-cardiac Chest Pain |
4.2% |
| Product Quality Issue |
4.2% |
| Withdrawal Syndrome |
4.2% |
| Agitation |
2.1% |
| Angioneurotic Oedema |
2.1% |
| Application Site Reaction |
2.1% |
| Cardiac Arrest |
2.1% |
| Cardiac Disorder |
2.1% |
| Convulsion |
2.1% |
| Deafness |
2.1% |
|
| Secondary |
| Product Used For Unknown Indication |
15.7% |
| Drug Use For Unknown Indication |
13.8% |
| Hypertonic Bladder |
13.2% |
| Urinary Incontinence |
13.2% |
| Pollakiuria |
10.1% |
| Osteoarthritis |
7.5% |
| Enuresis |
3.8% |
| Neurogenic Bladder |
3.8% |
| Micturition Urgency |
3.1% |
| Incontinence |
2.5% |
| Investigation |
2.5% |
| Affective Disorder |
1.9% |
| Blood Cholesterol Increased |
1.3% |
| Cardiac Disorder |
1.3% |
| Hypertension |
1.3% |
| Osteoporosis |
1.3% |
| Pain |
1.3% |
| Urinary Tract Infection |
1.3% |
| Anticoagulant Therapy |
0.6% |
| Bladder Spasm |
0.6% |
|
| Irritable Bowel Syndrome |
15.4% |
| Urinary Tract Infection |
12.8% |
| Drug Interaction |
7.7% |
| Sedation |
7.7% |
| Thinking Abnormal |
7.7% |
| Dry Mouth |
5.1% |
| Eye Pain |
5.1% |
| Product Quality Issue |
5.1% |
| Visual Field Defect |
5.1% |
| Alopecia |
2.6% |
| Death |
2.6% |
| Diplopia |
2.6% |
| Drug Ineffective |
2.6% |
| Dyspepsia |
2.6% |
| Grand Mal Convulsion |
2.6% |
| International Normalised Ratio Increased |
2.6% |
| Micturition Urgency |
2.6% |
| Nausea |
2.6% |
| Spinal Compression Fracture |
2.6% |
| Thrombosis |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.1% |
| Product Used For Unknown Indication |
12.2% |
| Multiple Sclerosis |
11.8% |
| Pain |
5.8% |
| Osteoporosis |
5.3% |
| Hypertension |
5.1% |
| Diabetes Mellitus |
3.9% |
| Depression |
3.7% |
| Hypertonic Bladder |
3.7% |
| Parkinson's Disease |
3.2% |
| Constipation |
2.8% |
| Urinary Incontinence |
2.8% |
| Somnolence |
2.5% |
| Insomnia |
2.3% |
| Urinary Tract Infection |
2.3% |
| Bipolar Disorder |
2.1% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Hypothyroidism |
1.9% |
| Dizziness |
1.8% |
| Relapsing-remitting Multiple Sclerosis |
1.8% |
|
| Urinary Tract Infection |
17.2% |
| Pyrexia |
7.1% |
| Vomiting |
7.1% |
| Weight Increased |
7.1% |
| Arthritis Infective |
5.1% |
| Restless Legs Syndrome |
5.1% |
| Tooth Abscess |
5.1% |
| Wrist Fracture |
5.1% |
| Drug Ineffective |
4.0% |
| Multiple Sclerosis |
4.0% |
| Nausea |
4.0% |
| Road Traffic Accident |
4.0% |
| Wound Infection Staphylococcal |
4.0% |
| Death |
3.0% |
| Dyspnoea |
3.0% |
| Hepatitis Cholestatic |
3.0% |
| Injury |
3.0% |
| Myalgia |
3.0% |
| Pancreatic Carcinoma |
3.0% |
| Rash |
3.0% |
|
| Interacting |
| Gastrooesophageal Reflux Disease |
50.0% |
| Hypertonic Bladder |
50.0% |
|
|
